Cancer Biologics Market Revenue 2024 to 2034
Cancer Biologics Market Revenue 2024 to 2034
The global cancer biologics market size is expected to increase from USD 119.41 billion in 2025 to USD 232.02 billion by 2034, growing at a CAGR of 7.66% throughout the forecast period from 2025 to 2034.
Report ID: 10189
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 110.91 Bn
Forecast Year,
USD USD 232.02 Bn
CAGR, 2025 -
7.66%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cancer Biologics Market Size Analysis
Cancer Biologics Market Size By Drug Class 2024 to 2034 (USD )
| Drug Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Monoclonal Antibodies | 31.05 | 33.52 | 36.18 | 39.05 | 42.15 | 45.49 | 49.10 | 52.99 | 57.20 | 61.73 | 66.63 |
| Cancer Growth Inhibitors | 16.64 | 17.95 | 19.37 | 20.90 | 22.56 | 24.34 | 26.27 | 28.34 | 30.58 | 33.00 | 35.61 |
| Vaccines | 13.31 | 14.28 | 15.32 | 16.43 | 17.63 | 18.91 | 20.29 | 21.77 | 23.35 | 25.05 | 26.87 |
| Recombinants Proteins | 11.09 | 11.90 | 12.78 | 13.72 | 14.72 | 15.80 | 16.96 | 18.20 | 19.54 | 20.97 | 22.51 |
| CAR-T Cells | 8.87 | 9.59 | 10.37 | 11.20 | 12.11 | 13.09 | 14.15 | 15.29 | 16.52 | 17.86 | 19.30 |
| Angiogenesis Inhibitors | 7.76 | 8.39 | 9.06 | 9.78 | 10.57 | 11.41 | 12.33 | 13.31 | 14.38 | 15.53 | 16.77 |
| Interleukins (IL) | 6.65 | 7.15 | 7.67 | 8.24 | 8.84 | 9.50 | 10.20 | 10.95 | 11.76 | 12.62 | 13.55 |
| Interferons (IFN) | 4.44 | 4.75 | 5.08 | 5.44 | 5.82 | 6.22 | 6.66 | 7.13 | 7.62 | 8.16 | 8.73 |
| Gene Therapy | 5.55 | 6.00 | 6.49 | 7.02 | 7.60 | 8.22 | 8.89 | 9.62 | 10.41 | 11.26 | 12.18 |
| Others | 5.55 | 5.88 | 6.24 | 6.61 | 7.00 | 7.42 | 7.86 | 8.32 | 8.81 | 9.33 | 9.87 |
Cancer Biologics Market Size By Applications 2024 to 2034 (USD )
| Applications | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood Cancer | 16.64 | 17.95 | 19.36 | 20.88 | 22.53 | 24.30 | 26.22 | 28.28 | 30.51 | 32.91 | 35.50 |
| Lung Cancer | 15.53 | 16.74 | 18.05 | 19.46 | 20.98 | 22.62 | 24.39 | 26.29 | 28.34 | 30.56 | 32.95 |
| Breast Cancer | 14.42 | 15.50 | 16.66 | 17.91 | 19.25 | 20.69 | 22.24 | 23.91 | 25.70 | 27.63 | 29.70 |
| Colorectal Cancer | 13.31 | 14.34 | 15.45 | 16.65 | 17.94 | 19.33 | 20.83 | 22.44 | 24.18 | 26.05 | 28.07 |
| Prostate Cancer | 11.09 | 11.96 | 12.91 | 13.92 | 15.02 | 16.20 | 17.48 | 18.85 | 20.34 | 21.94 | 23.67 |
| Gastric Cancer | 8.87 | 9.54 | 10.26 | 11.03 | 11.86 | 12.75 | 13.71 | 14.74 | 15.85 | 17.05 | 18.33 |
| Ovarian Cancer | 8.87 | 9.54 | 10.26 | 11.03 | 11.86 | 12.75 | 13.71 | 14.74 | 15.85 | 17.05 | 18.33 |
| Skin Cancer | 7.76 | 8.37 | 9.02 | 9.73 | 10.49 | 11.31 | 12.19 | 13.15 | 14.17 | 15.28 | 16.47 |
| Liver Cancer | 7.76 | 8.35 | 8.97 | 9.65 | 10.37 | 11.15 | 11.99 | 12.89 | 13.85 | 14.89 | 16.01 |
| Others | 6.65 | 7.12 | 7.61 | 8.14 | 8.70 | 9.30 | 9.95 | 10.64 | 11.37 | 12.15 | 12.99 |
Cancer Biologics Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 72.09 | 77.65 | 83.64 | 90.08 | 97.03 | 104.51 | 112.57 | 121.25 | 130.59 | 140.66 | 151.51 |
| Cancer Center | 27.73 | 29.86 | 32.16 | 34.64 | 37.31 | 40.18 | 43.28 | 46.61 | 50.20 | 54.07 | 58.24 |
| Academics & Research Institutes | 11.09 | 11.89 | 12.75 | 13.67 | 14.66 | 15.72 | 16.86 | 18.07 | 19.38 | 20.77 | 22.27 |
Cancer Biologics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 44.36 | 47.80 | 51.50 | 55.48 | 59.78 | 64.41 | 69.39 | 74.76 | 80.55 | 86.78 | 93.50 |
| Asia Pacific | 27.73 | 29.88 | 32.19 | 34.68 | 37.37 | 40.26 | 43.38 | 46.74 | 50.36 | 54.26 | 58.47 |
| Europe | 22.18 | 23.86 | 25.66 | 27.60 | 29.68 | 31.92 | 34.33 | 36.93 | 39.71 | 42.71 | 45.94 |
| Latin America | 11.09 | 11.93 | 12.83 | 13.80 | 14.84 | 15.96 | 17.17 | 18.46 | 19.86 | 21.36 | 22.97 |
| Middle East and Africa | 5.55 | 5.95 | 6.38 | 6.84 | 7.33 | 7.86 | 8.43 | 9.04 | 9.69 | 10.39 | 11.14 |
Cancer Biologics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
